Signal transduction by vascular endothelial growth factor receptors

Related Experiment Video

Updated: May 20, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Sina Koch1, Lena Claesson-Welsh

  • 1Uppsala University, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, 751 85 Uppsala, Sweden.

Cold Spring Harbor Perspectives in Medicine
|July 5, 2012
PubMed

Insights

Vascular endothelial growth factors (VEGFs) regulate blood and lymphatic vessel function. Understanding VEGF signaling is key for developing therapies targeting angiogenesis in diseases like cancer.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Physiology

Background:

  • Vascular endothelial growth factors (VEGFs) are crucial for vascular development and function.
  • VEGFs signal through receptor tyrosine kinases (RTKs) and coreceptors like neuropilins (NRPs) and integrins.
  • Dysregulated VEGF signaling is implicated in diseases such as cancer, driving angiogenesis.

Purpose of the Study:

  • To review the current understanding of VEGF signal transduction.
  • To explore the role of VEGF signaling in blood and lymphatic vessel biology.
  • To provide context for the development of VEGF-targeted therapeutics.

Main Methods:

  • Literature review of scientific publications on VEGF signaling.
  • Analysis of molecular mechanisms of VEGF-RTK interactions.
  • Examination of the role of coreceptors in modulating VEGF pathways.

Main Results:

  • VEGFs comprise a family of five mammalian ligands.
  • Three RTKs mediate VEGF signaling, with modulation by NRPs and integrins.
  • VEGF signaling is a critical target for anti-angiogenic therapies.

Conclusions:

  • VEGF signaling pathways are complex and vital for vascular homeostasis.
  • Targeting VEGF components offers therapeutic potential for angiogenesis-dependent diseases.
  • Further research into VEGF signal transduction can refine therapeutic strategies.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: